BackBristol-Myers Squibb Company Ce Overview
Bristol-Myers Squibb Company Ce

Bristol-Myers Squibb Company Ce Return on Equity

Bristol-Myers Squibb Company Ce (CELG-RI) has a ROE of 39.49%, above the sector sector average of 11.67%.

Get informed when a big investor buys or sells

+ Follow

ROE

39.49%

Return on Equity

39.49%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Bristol-Myers Squibb Company Ce (CELG-RI) FAQ

As of the most recent data, CELG-RI shows a ROE of 39.49%. That is above the sector sector average of 11.67%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.67%. Bristol-Myers Squibb Company Ce is at 39.49%, which is higher that average. That is roughly 238.5% above the sector mean. Use the comparison chart on this page to see how CELG-RI stacks up against individual peers as well.

Check the historical chart to see whether CELG-RI's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Bristol-Myers Squibb Company Ce with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Bristol-Myers Squibb Company Ce's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 39.49%) with ownership activity and broader fundamentals.